Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3827 ARTÍCULOS , VIENDO DEL 3616 AL 3630

PINK1 parkinsonism and Parkinson disease: distinguishable brain mitochondrial function and metabolomics

Rango M, Arighi A, Marotta G, Ronchi D, Bresolin N.

Mitochondrion. 2013 Jan;13(1):59-61. doi: 10.1016/j.mito.2012.10.004. Epub 2012 Oct 10.

Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism

Hauser DN, Hastings TG.

Neurobiol Dis. 2013 Mar;51:35-42. doi: 10.1016/j.nbd.2012.10.011. Epub 2012 Oct 12.

Potential therapeutic applications of differentiated induced pluripotent stem cells (iPSCs) in the treatment of neurodegenerative diseases

Gao A, Peng Y, Deng Y, Qing H.

Neuroscience. 2013 Jan 3;228:47-59. doi: 10.1016/j.neuroscience.2012.09.076. Epub 2012 Oct 13.

Usefulness of OSLER test in Parkinson's disease

Ferreira JJ, Neutel D, Mestre TA, Galitzky M, Thalamas C, Santos AT, Sampaio C, Rascol O.

Sleep Med. 2013 Mar;14(3):297-8. doi: 10.1016/j.sleep.2012.09.005. Epub 2012 Oct 13.

Comparison of rating scales used to evaluate L-DOPA-induced dyskinesia in the 6-OHDA lesioned rat

Breger LS, Dunnett SB, Lane EL.

Neurobiol Dis. 2013 Feb;50:142-50. doi: 10.1016/j.nbd.2012.10.013. Epub 2012 Oct 13.

Memantine for axial signs in Parkinson's disease: a randomised, double-blind, placebo-controlled pilot study

Moreau C, Delval A, Tiffreau V, Defebvre L, Dujardin K, Duhamel A, Petyt G, Hossein-Foucher C, Blum D, Sablonnière B, Schraen S, Allorge D, Destée A, Bordet R, Devos D.

J Neurol Neurosurg Psychiatry. 2013 May;84(5):552-5. doi: 10.1136/jnnp-2012-303182. Epub 2012 Oct 16.

Activity-dependent, stress-responsive BDNF signaling and the quest for optimal brain health and resilience throughout the lifespan

Rothman SM, Mattson MP.

Neuroscience. 2013 Jun 3;239:228-40. doi: 10.1016/j.neuroscience.2012.10.014. Epub 2012 Oct 16.

A stroke of silence: tinnitus suppression following placement of a deep brain stimulation electrode with infarction in area LC

Larson PS, Cheung SW.

J Neurosurg. 2013 Jan;118(1):192-4. doi: 10.3171/2012.9.JNS12594. Epub 2012 Oct 19.

Istradefylline, an adenosine A₂A receptor antagonist, for patients with Parkinson's Disease: a meta-analysis

Chen W, Wang H, Wei H, Gu S, Wei H.

J Neurol Sci. 2013 Jan 15;324(1-2):21-8. doi: 10.1016/j.jns.2012.08.030. Epub 2012 Oct 22.

Neuroprotective effect of estrogen: role of nonsynaptic NR2B-containing NMDA receptors

Liu SB, Zhao MG.

Brain Res Bull. 2013 Apr;93:27-31. doi: 10.1016/j.brainresbull.2012.10.004. Epub 2012 Oct 17.

Parkinsonism in cirrhosis: pathogenesis and current therapeutic options

Butterworth RF.

Metab Brain Dis. 2013 Jun;28(2):261-7. doi: 10.1007/s11011-012-9341-7. Epub 2012 Oct 20.

Calcium, bioenergetics, and neuronal vulnerability in Parkinson's disease

Surmeier DJ, Schumacker PT.

J Biol Chem. 2013 Apr 12;288(15):10736-41. doi: 10.1074/jbc.R112.410530. Epub 2012 Oct 19.

Parkinson's disease: evidence for environmental risk factors

Kieburtz K, Wunderle KB.

Mov Disord. 2013 Jan;28(1):8-13. doi: 10.1002/mds.25150. Epub 2012 Oct 24.

Intracerebral abscess: a rare complication of Deep Brain Stimulation

Brandão E, Rosas MJ, Abreu P, Linhares P, Vaz R.

Neurocirugia (Astur). 2013 Jan-Feb;24(1):33-6. doi: 10.1016/j.neucir.2011.11.008. Epub 2012 Oct 24.

Long-term effects of ionising radiation on the brain: cause for concern?

Kempf SJ, Azimzadeh O, Atkinson MJ, Tapio S.

Radiat Environ Biophys. 2013 Mar;52(1):5-16. doi: 10.1007/s00411-012-0436-7. Epub 2012 Oct 26.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias